Siglec-15 promotes progression of clear renal cell carcinoma

被引：4

作者：

Wen-Bo Yang

Cai-Peng Qin

Yi-Qing Du

Song-Chen Han

Tao Xu

机构：

[1] Beijing 100044

[2] ChinaDepartment of Urology

[3] Department of Urology

[4] Peking University People’s Hospital

来源：

中华医学杂志(英文版) | 2021年 / 134卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R737.11 [肾、肾盂肿瘤];

学科分类号：

100214 ;

摘要：

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, accounting for approximately 80% of cases. Although most patients in the early stages of ccRCC can be cured

引用

页码：2635 / 2637

页数：3

共 50 条

[21] Normalization cancer immunotherapy: blocking Siglec-15!
Cao, Guangchao
Xiao, Zhiqiang
Yin, Zhinan
[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
[22] Siglec-15 Silencing Inhibits Cell Proliferation and Promotes Cell Apoptosis by Inhibiting STAT1/STAT3 Signaling in Anaplastic Thyroid Carcinoma
Hou, Xiaofeng
Chen, Chao
He, Xiaodong
Lan, Xiabin
[J]. DISEASE MARKERS, 2022, 2022
[23] Normalization cancer immunotherapy: blocking Siglec-15!
Guangchao Cao
Zhiqiang Xiao
Zhinan Yin
[J]. Signal Transduction and Targeted Therapy, 4
[24] Siglec-15: an immune system Siglec conserved throughout vertebrate evolution
Angata, Takashi
Tabuchi, Yukako
Nakamura, Kazunori
Nakamura, Mitsuru
[J]. GLYCOBIOLOGY, 2007, 17 (08) : 838 - 846
[25] KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation
Li, Gang
Xie, Zun-Ke
Zhu, Dong-Sheng
Guo, Tao
Cai, Qi-Liang
Wang, Yi
[J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 16517 - 16525
[26] MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
Neumann, Chase K. A.
Silver, Daniel J.
Venkateshwari, Varadharajan
Zhang, Renliang
Traughber, C. Alicia
Przybycin, Christopher
Bayik, Defne
Smith, Jonathan D.
Lathia, Justin D.
Rini, Brian, I
Brown, J. Mark
[J]. MOLECULAR METABOLISM, 2020, 34 : 136 - 145
[27] PPARγ is dispensable for clear cell renal cell carcinoma progression
Sanchez, Danielle J.
Steger, David J.
Skuli, Nicolas
Bansal, Ankita
Simon, M. Celeste
[J]. MOLECULAR METABOLISM, 2018, 14 : 139 - 149
[28] Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer
Shafi, Saba
Aung, Thazin Nwe
Xirou, Vasiliki
Gavrielatou, Niki
Vathiotis, Ioannis A.
Fernandez, Aileen
Moutafi, Myrto
Yaghoobi, Vesal
Herbst, Roy S.
Liu, Linda N.
Langermann, Sol
Rimm, David L.
[J]. LABORATORY INVESTIGATION, 2022, 102 (10) : 1143 - 1149
[29] CLINICAL BENEFIT THROUGH SIGLEC-15 TARGETING WITH NC318 ANTIBODY IN SUBJECTS WITH SIGLEC-15 POSITIVE ADVANCED SOLID TUMORS
Shum, Elaine
Myint, Han
Shaik, Jahangheer
Zhou, Qinjie
Barbu, Emilia
Morawski, Aaron
Abukharma, Hasan
Liu, Linda
Nelson, Megan
Zeidan, Stephanie
Cusumano, Zachary
Tolcher, Anthony
Langermann, Solomon
Gutierrez, Martin
Hamid, Omid
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A520 - A521
[30] CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
Qi Wang
Jiaju Xu
Zhiyong Xiong
Tianbo Xu
Jingchong Liu
Yuenan Liu
Jiaping Chen
Jian Shi
Yi Shou
Changjie Yue
Di Liu
Huageng Liang
Hongmei Yang
Xiong Yang
Xiaoping Zhang
[J]. Journal of Translational Medicine, 19

← 1 2 3 4 5 →